Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial
Resource Type
Article
Authors
Garcia-Manero, Guillermo ; Roboz, Gail ; Walsh, Katherine ; Kantarjian, Hagop ; Ritchie, Ellen ; Kropf, Patricia ; O'Connell, Casey ; Tibes, Raoul ; Lunin, Scott ; Rosenblat, Todd ; Yee, Karen ; Stock, Wendy ; Griffiths, Elizabeth ; Mace, Joseph ; Podoltsev, Nikolai ; Berdeja, Jesus ; Jabbour, Elias ; Issa, Jean-Pierre J ; Hao, Yong ; Keer, Harold N ; Azab, Mohammad ; Savona, Michael R
Source
In The Lancet Haematology June 2019 6(6):e317-e327
Subject
Primary Research Articles
Language
ISSN
2352-3026